GlaxoSmithKline Biologicals; Branch of SmithKline Beecham Pharma GmbH & Co. KG
发明人:
Eichhorn, Uwe
申请号：
AU2002344182
公开号：
AU2002344182C1
申请日:
2002.05.29
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
An inactivated influenza virus preparation is described which comprises a haemagglutininantigen stabilised in the absence of thiomersal, or at low levels of thiomersal,wherein the haemagglutinin is detectable by a SRD assay. The influenza viruspreparation may comprise a micelle modifying excipient, for example αtocopherol or a derivative thereof in a sufficient amount to stabilise the haemagglutinin.
